These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32572108)

  • 1. Growth Differentiation Factor 15 is a potential biomarker of therapeutic response for TK2 deficient myopathy.
    Dominguez-Gonzalez C; Badosa C; Madruga-Garrido M; Martí I; Paradas C; Ortez C; Diaz-Manera J; Berardo A; Alonso-Pérez J; Trifunov S; Cuadras D; Kalko SG; Blázquez-Bermejo C; Cámara Y; Martí R; Mavillard F; Martin MA; Montoya J; Ruiz-Pesini E; Villarroya J; Montero R; Villarroya F; Artuch R; Hirano M; Nascimento A; Jimenez-Mallebrera C
    Sci Rep; 2020 Jun; 10(1):10111. PubMed ID: 32572108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GDF-15 Is Elevated in Children with Mitochondrial Diseases and Is Induced by Mitochondrial Dysfunction.
    Montero R; Yubero D; Villarroya J; Henares D; Jou C; Rodríguez MA; Ramos F; Nascimento A; Ortez CI; Campistol J; Perez-Dueñas B; O'Callaghan M; Pineda M; Garcia-Cazorla A; Oferil JC; Montoya J; Ruiz-Pesini E; Emperador S; Meznaric M; Campderros L; Kalko SG; Villarroya F; Artuch R; Jimenez-Mallebrera C
    PLoS One; 2016; 11(2):e0148709. PubMed ID: 26867126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies.
    Kalko SG; Paco S; Jou C; Rodríguez MA; Meznaric M; Rogac M; Jekovec-Vrhovsek M; Sciacco M; Moggio M; Fagiolari G; De Paepe B; De Meirleir L; Ferrer I; Roig-Quilis M; Munell F; Montoya J; López-Gallardo E; Ruiz-Pesini E; Artuch R; Montero R; Torner F; Nascimento A; Ortez C; Colomer J; Jimenez-Mallebrera C
    BMC Genomics; 2014 Feb; 15():91. PubMed ID: 24484525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of current serum biomarkers as diagnostic indicators of mitochondrial diseases.
    Davis RL; Liang C; Sue CM
    Neurology; 2016 May; 86(21):2010-5. PubMed ID: 27164684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma FGF-21 and GDF-15 are elevated in different inherited metabolic diseases and are not diagnostic for mitochondrial disorders.
    Tsygankova PG; Itkis YS; Krylova TD; Kurkina MV; Bychkov IO; Ilyushkina AA; Zabnenkova VV; Mikhaylova SV; Pechatnikova NL; Sheremet NL; Zakharova EY
    J Inherit Metab Dis; 2019 Sep; 42(5):918-933. PubMed ID: 31260105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Mitochondrial Biomarkers FGF-21 and GDF-15 in Patients with Episodic and Chronic Migraine.
    Burow P; Haselier M; Naegel S; Scholle LM; Gaul C; Kraya T
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GDF-15, a mitochondrial disease biomarker, is associated with the severity of multiple sclerosis.
    Nohara S; Ishii A; Yamamoto F; Yanagiha K; Moriyama T; Tozaka N; Miyake Z; Yatsuga S; Koga Y; Hosaka T; Terada M; Yamaguchi T; Aizawa S; Mamada N; Tsuji H; Tomidokoro Y; Nakamagoe K; Ishii K; Watanabe M; Tamaoka A
    J Neurol Sci; 2019 Oct; 405():116429. PubMed ID: 31476622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders.
    Yatsuga S; Fujita Y; Ishii A; Fukumoto Y; Arahata H; Kakuma T; Kojima T; Ito M; Tanaka M; Saiki R; Koga Y
    Ann Neurol; 2015 Nov; 78(5):814-23. PubMed ID: 26463265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability and cytosolic kinases modulate response to deoxynucleoside therapy in TK2 deficiency.
    Lopez-Gomez C; Hewan H; Sierra C; Akman HO; Sanchez-Quintero MJ; Juanola-Falgarona M; Tadesse S; Tanji K; Konofagou EE; Hirano M
    EBioMedicine; 2019 Aug; 46():356-367. PubMed ID: 31383553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Gelsolin Reinforces the Diagnostic Value of FGF-21 and GDF-15 for Mitochondrial Disorders.
    Peñas A; Fernández-De la Torre M; Laine-Menéndez S; Lora D; Illescas M; García-Bartolomé A; Morales-Conejo M; Arenas J; Martín MA; Morán M; Domínguez-González C; Ugalde C
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deoxynucleoside Therapy for Thymidine Kinase 2-Deficient Myopathy.
    Domínguez-González C; Madruga-Garrido M; Mavillard F; Garone C; Aguirre-Rodríguez FJ; Donati MA; Kleinsteuber K; Martí I; Martín-Hernández E; Morealejo-Aycinena JP; Munell F; Nascimento A; Kalko SG; Sardina MD; Álvarez Del Vayo C; Serrano O; Long Y; Tu Y; Levin B; Thompson JLP; Engelstad K; Uddin J; Torres-Torronteras J; Jimenez-Mallebrera C; Martí R; Paradas C; Hirano M
    Ann Neurol; 2019 Aug; 86(2):293-303. PubMed ID: 31125140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGF-21 as a Potential Biomarker for Mitochondrial Diseases.
    Scholle LM; Lehmann D; Deschauer M; Kraya T; Zierz S
    Curr Med Chem; 2018; 25(18):2070-2081. PubMed ID: 29332568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Thymidine Kinase 2 Deficiency: Clinical Aspects, Translational Progress, and Emerging Therapies.
    Berardo A; Domínguez-González C; Engelstad K; Hirano M
    J Neuromuscul Dis; 2022; 9(2):225-235. PubMed ID: 35094997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic Deoxynucleoside and Gene Therapies for Thymidine Kinase 2 Deficiency.
    Lopez-Gomez C; Sanchez-Quintero MJ; Lee EJ; Kleiner G; Tadesse S; Xie J; Akman HO; Gao G; Hirano M
    Ann Neurol; 2021 Oct; 90(4):640-652. PubMed ID: 34338329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum fibroblast growth factor 21 and growth differentiation factor 15: Two sensitive biomarkers in the diagnosis of mitochondrial disorders.
    Huddar A; Govindaraj P; Chiplunkar S; Deepha S; Jessiena Ponmalar JN; Philip M; Nagappa M; Narayanappa G; Mahadevan A; Sinha S; Taly AB; Parayil Sankaran B
    Mitochondrion; 2021 Sep; 60():170-177. PubMed ID: 34419687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related metabolic changes limit efficacy of deoxynucleoside-based therapy in thymidine kinase 2-deficient mice.
    Blázquez-Bermejo C; Molina-Granada D; Vila-Julià F; Jiménez-Heis D; Zhou X; Torres-Torronteras J; Karlsson A; Martí R; Cámara Y
    EBioMedicine; 2019 Aug; 46():342-355. PubMed ID: 31351931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late-onset thymidine kinase 2 deficiency: a review of 18 cases.
    Domínguez-González C; Hernández-Laín A; Rivas E; Hernández-Voth A; Sayas Catalán J; Fernández-Torrón R; Fuiza-Luces C; García García J; Morís G; Olivé M; Miralles F; Díaz-Manera J; Caballero C; Méndez-Ferrer B; Martí R; García Arumi E; Badosa MC; Esteban J; Jimenez-Mallebrera C; Encinar AB; Arenas J; Hirano M; Martin MÁ; Paradas C
    Orphanet J Rare Dis; 2019 May; 14(1):100. PubMed ID: 31060578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deoxycytidine and Deoxythymidine Treatment for Thymidine Kinase 2 Deficiency.
    Lopez-Gomez C; Levy RJ; Sanchez-Quintero MJ; Juanola-Falgarona M; Barca E; Garcia-Diaz B; Tadesse S; Garone C; Hirano M
    Ann Neurol; 2017 May; 81(5):641-652. PubMed ID: 28318037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective natural history of thymidine kinase 2 deficiency.
    Garone C; Taylor RW; Nascimento A; Poulton J; Fratter C; Domínguez-González C; Evans JC; Loos M; Isohanni P; Suomalainen A; Ram D; Hughes MI; McFarland R; Barca E; Lopez Gomez C; Jayawant S; Thomas ND; Manzur AY; Kleinsteuber K; Martin MA; Kerr T; Gorman GS; Sommerville EW; Chinnery PF; Hofer M; Karch C; Ralph J; Cámara Y; Madruga-Garrido M; Domínguez-Carral J; Ortez C; Emperador S; Montoya J; Chakrapani A; Kriger JF; Schoenaker R; Levin B; Thompson JLP; Long Y; Rahman S; Donati MA; DiMauro S; Hirano M
    J Med Genet; 2018 Aug; 55(8):515-521. PubMed ID: 29602790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth and differentiation factor 15 as a biomarker for mitochondrial myopathy.
    Poulsen NS; Madsen KL; Hornsyld TM; Eisum AV; Fornander F; Buch AE; Stemmerik MG; Ruiz-Ruiz C; Krag TO; Vissing J
    Mitochondrion; 2020 Jan; 50():35-41. PubMed ID: 31669236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.